The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP/PS1 miceLeticia Forny Germano, Daniel J. Drucker, Dianne Matthews et al.|Molecular Metabolism|2024Cited by 37